NCT07380412NARecruitingAccepts Healthy Volunteers

A Study to Evaluate the Effects of a Supplement on the Side Effects Associated With Stimulant Medications

Outliers, Inc.

Start Date

8/12/2025

Completion Date

3/1/2026

Summary

This is a hybrid, two-arm, triple-blind, placebo-controlled, randomized clinical trial evaluating the efficacy of the Stasis supplement on reducing oxidative stress, cortisol levels, and side effects associated with stimulant medications used for ADHD over a three-month period in adults.

Eligibility Criteria

Age Range: 18 years to 55 years

Inclusion Criteria: * Aged 18-55 years * Currently prescribed stimulant medication for ADHD * Experiencing: sleep difficulty, irritability, anxiety, brain fog * Stable medication dose ≥3 months * Healthy with no uncontrolled chronic conditions * Stable on supplements ≥3 months if applicable * US resident * Willing to maintain current habits Exclusion Criteria: * Chronic conditions (e.g. cancer, mental illness) * Use of psychiatric medications besides stimulants * Pregnancy, breastfeeding, thyroid, liver, kidney conditions * Recent smokers or heavy alcohol use * Night shift workers * Participation in other clinical trials * Allergies to product ingredients

Interventions

DIETARY_SUPPLEMENT

Stasis Daytime and Nighttime

DIETARY_SUPPLEMENT

Placebo

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

ADHDSleep DisturbanceBrain Fog

Locations

Citruslabs

Las Vegas, Nevada 89118

United States